BiotechTube

Estradiol + placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Menopause

Conditions

Menopause, Vulvovaginal Atrophy, Painful Intercourse, Dyspareunia

Trial Timeline

Jul 1, 2013 → Sep 1, 2013

NCT ID
NCT02449902

About Estradiol + placebo

Estradiol + placebo is a phase 2 stage product being developed by TherapeuticsMD for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT02449902. Target conditions include Menopause, Vulvovaginal Atrophy, Painful Intercourse.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT02253173Phase 3Completed
NCT02449902Phase 2Completed

Competing Products

20 competing products in Menopause

See all competitors
ProductCompanyStageHype Score
atomoxetine + placeboEli LillyPre-clinical
23
Fezolinetant + PlaceboAstellas PharmaPhase 2
52
CetrorelixShionogiPre-clinical
23
Teriparatide (PTH 1-34)Eli LillyPhase 2/3
65
Eszopiclone + PlaceboSumitomo PharmaPre-clinical
23
Comparator: placebo + Comparator: EstraceMerckPhase 1
33
esmirtazapine + PlaceboMerckPhase 3
77
Marketed low dose hormone replacement therapyNovo NordiskPre-clinical
22
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)Novo NordiskPre-clinical
22
1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)Novo NordiskApproved
84
estradiol, 10 mcg + estradiol, 25 mcg + placeboNovo NordiskPhase 3
76
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)Novo NordiskPhase 1
32
estradiol, 25 mcgNovo NordiskPre-clinical
22
estradiol, 10 mcgNovo NordiskPhase 3
76
estradiol, 10 mcg + estradiol, 25 mcgNovo NordiskPhase 1
32
estradiol, 10 mcgNovo NordiskPhase 3
76
2 mg estradiol / 1 mg norethisterone acetate (NETA)Novo NordiskPhase 1
32
estradiol, 25 mcgNovo NordiskPhase 3
76
estradiol, 25 mcgNovo NordiskPhase 3
76
0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + placeboNovo NordiskPhase 3
76

Other Products from TherapeuticsMD

Progesterone + PlaceboPhase 3
69
Estradiol + Progesterone + PlaceboPhase 3
69
Estradiol + PlaceboPhase 3
69
oral estradiol 1.0 mg + oral progesterone 100 mgPhase 3
69
Segesterone Acetate and Ethinyl EstradiolPhase 1
25